DIAGNOS (CVE:ADK) Shares Down 1.5% – Should You Sell?

DIAGNOS Inc. (CVE:ADK) shares were down 1.5% during trading on Tuesday . The stock traded as low as C$0.33 and last traded at C$0.34. Approximately 103,500 shares were traded during mid-day trading, an increase of 14% from the average daily volume of 90,800 shares. The stock had previously closed at C$0.34.

Analyst Upgrades and Downgrades

Separately, Ventum Cap Mkts upgraded DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.

DIAGNOS Stock Performance

The stock has a market cap of C$27.28 million, a PE ratio of -8.38 and a beta of -0.44. The company has a fifty day moving average price of C$0.36 and a 200 day moving average price of C$0.32. The company has a quick ratio of 0.68, a current ratio of 0.39 and a debt-to-equity ratio of 245.28.

DIAGNOS (CVE:ADK) last released its quarterly earnings data on Wednesday, August 21st. The company reported C($0.01) EPS for the quarter, topping the consensus estimate of C($0.02) by C$0.01. The company had revenue of C$0.04 million during the quarter, compared to analysts’ expectations of C$0.07 million. Analysts expect that DIAGNOS Inc. will post -0.02 earnings per share for the current year.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.